SINO BIOPHARM (01177): 45 research results will be presented at the ASCO annual meeting in 2025.
China Biopharmaceuticals (01177) announced that the group will participate in the American Society of Clinical Oncology (ASCO) in 2025...
SINO BIOPHARM (01177) announces that the group will release 45 latest research results at the American Society of Clinical Oncology (ASCO) Annual Meeting in 2025, including 12 oral presentations and 4 significant research abstracts (LBA).
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


